John A. Green

4.6k total citations · 3 hit papers
38 papers, 3.5k citations indexed

About

John A. Green is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, John A. Green has authored 38 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in John A. Green's work include Endometrial and Cervical Cancer Treatments (8 papers), Colorectal and Anal Carcinomas (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). John A. Green is often cited by papers focused on Endometrial and Cervical Cancer Treatments (8 papers), Colorectal and Anal Carcinomas (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). John A. Green collaborates with scholars based in United Kingdom, Italy and France. John A. Green's co-authors include Paul Symonds, Mandy Collingwood, Jayne F. Tierney, Christopher J. Williams, John Kirwan, Lydia Fresco, Scot E. Dowd, Denise Molitoris, Minghsun Liu and Viktoria Gontcharova and has published in prestigious journals such as The Lancet, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

John A. Green

36 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis

2001 871 citations John A. Green, John Kirwan et al. The Lancet profile →
Pyrosequencing study of fecal microflora of autistic and control children

2010 749 citations John A. Green et al. profile →
Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.

1983 470 citations John A. Green et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John A. Green United Kingdom	18	1.2k	1.1k	842	728	612	38	3.5k
J. Dietl Germany	42	1.1k 0.9×	1.6k 1.4×	340 0.4×	1.2k 1.6×	1.2k 1.9×	229	5.8k
Richard E. Buller United States	42	1.1k 0.9×	1.4k 1.3×	587 0.7×	1.5k 2.0×	1.8k 2.9×	118	4.7k
Naohiro Kanayama Japan	35	1.2k 1.0×	923 0.8×	301 0.4×	306 0.4×	277 0.5×	252	4.4k
George D. Wilbanks United States	31	1.3k 1.1×	1.1k 1.0×	471 0.6×	1.3k 1.8×	1.6k 2.7×	107	4.6k
Peng‐Hui Wang Taiwan	43	2.7k 2.3×	1.1k 0.9×	1.1k 1.3×	569 0.8×	2.9k 4.8×	368	6.7k
Olaf Ortmann Germany	41	619 0.5×	1.6k 1.4×	368 0.4×	1.7k 2.4×	2.2k 3.6×	346	6.3k
Tsuyoshi Saito Japan	37	791 0.7×	1.6k 1.5×	332 0.4×	785 1.1×	930 1.5×	211	4.2k
Alain G. Zeimet Austria	43	479 0.4×	2.2k 2.0×	607 0.7×	2.1k 2.8×	1.3k 2.1×	173	5.1k
Yutaka Tomoda Japan	36	849 0.7×	1.1k 1.0×	610 0.7×	629 0.9×	1.1k 1.8×	253	4.2k
Andrea Ciavattini Italy	34	2.1k 1.7×	702 0.6×	610 0.7×	522 0.7×	1.5k 2.5×	251	4.3k

Countries citing papers authored by John A. Green

Since Specialization

Citations

This map shows the geographic impact of John A. Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Green more than expected).

Fields of papers citing papers by John A. Green

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Green. The network helps show where John A. Green may publish in the future.

Co-authorship network of co-authors of John A. Green

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Green. A scholar is included among the top collaborators of John A. Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Green. John A. Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Greenhalgh, J, Angela Boland, Fabio Maria Vecchio, et al.. (2021). First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer. Cochrane Database of Systematic Reviews. 2021(3). 55 indexed citations

Pautier, Patricia, Ignace Vergote, Florence Joly, et al.. (2016). A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer. International Journal of Gynecological Cancer. 27(2). 258–266. 32 indexed citations

Green, John A., Y Dündar, Susanna Dodd, Rumona Dickson, & Tom Walley. (2007). Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma. Cochrane Database of Systematic Reviews. 2012(4). CD005574–CD005574. 24 indexed citations

Green, John A., Jayne F. Tierney, Claire L. Vale, et al.. (2005). Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database of Systematic Reviews. 2015(2). CD002225–CD002225. 305 indexed citations

Kirwan, John, Paul Symonds, John A. Green, et al.. (2003). A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiotherapy and Oncology. 68(3). 217–226. 255 indexed citations

Green, John A., John Kirwan, Jayne F. Tierney, et al.. (2001). Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. The Lancet. 358(9284). 781–786. 871 indexed citations breakdown →

Green, John A., et al.. (1996). Fair and effective resource allocation in cancer care: uncharted territory?. PubMed. 4(1). 19–44. 1 indexed citations

Green, John A.. (1996). Fair and Effective Resource Allocation in Cancer Care: Uncharted Territory? Paper One: Resource Allocation in Cancer Medicine: Invest Where the Benefits are Clear. Health Care Analysis. 4(1). 19–28. 2 indexed citations

Giles, Richard V., et al.. (1995). Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cells. Nucleic Acids Research. 23(6). 954–961. 71 indexed citations

10.

Pendleton, Neil, et al.. (1993). Expression of proliferating cell nuclear antigen (PCNA) in dysplasia of the bronchial epithelium. The Journal of Pathology. 170(2). 169–172. 26 indexed citations

11.

Husband, David & John A. Green. (1992). chemotherapy in non-seminomatous germ cell tumours: Outcome and importance of dose intensity. European Journal of Cancer. 28(1). 86–91. 22 indexed citations

12.

Britten, Richard A., John A. Green, & Hilmar M. Warenius. (1992). Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents. International Journal of Radiation Oncology*Biology*Physics. 24(3). 527–531. 65 indexed citations

13.

Green, John A., et al.. (1990). Dose intensity of carboplatin in combination with cyclophosphamide or ifosfamide. Cancer Chemotherapy and Pharmacology. 26(S1). S22–S25. 8 indexed citations

14.

Green, John A., et al.. (1989). Alternating six-drug combination chemotherapy induction for intermediate and high-grade non-Hodgkin's lymphoma. Cancer Chemotherapy and Pharmacology. 24(5). 326–328.

15.

Green, John A.. (1989). After Goldie-Coldman—Where now?. European Journal of Cancer and Clinical Oncology. 25(5). 913–916. 5 indexed citations

16.

Husband, David, et al.. (1989). Ifosfamide encephalopathy: a reappraisal. European Journal of Cancer and Clinical Oncology. 25(9). 1303–1310. 36 indexed citations

17.

Speth, P A, Martin Gore, David R. Newell, et al.. (1988). Phase I and pharmacokinetic studies with the pentacyclic pyrroloquinone mitoquidone. Cancer Chemotherapy and Pharmacology. 21(4). 343–346. 5 indexed citations

18.

Donald, David, et al.. (1980). Mycosis fungoides associated with nodular sclerosing Hodgkin's disease: A case report. Cancer. 46(11). 2505–2508. 34 indexed citations

19.

Green, John A.. (1970). Introduction to measurement and evaluation. 21 indexed citations

20.

Green, John A., et al.. (1966). L'Essentiel de la grammaire francaise. Modern Language Journal. 50(1). 56–56. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact